Cargando…
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
The recent pandemic, Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has devastated humanity and is continuing to threaten us. Due to the high transmissibility of this pathogen, researchers are still trying to cope with the treatment and pre...
Autores principales: | Punekar, Madhura, Kshirsagar, Manas, Tellapragada, Chaitanya, Patil, Kanchankumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160731/ https://www.ncbi.nlm.nih.gov/pubmed/35654381 http://dx.doi.org/10.1016/j.micpath.2022.105608 |
Ejemplares similares
-
Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
Corrigendum: Drug repurposing approach against chikungunya virus: an in vitro and in silico study
por: Kasabe, Bhagyashri, et al.
Publicado: (2023) -
Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022) -
A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2
por: Punekar, Madhura, et al.
Publicado: (2022) -
Repurposing calcium channel blockers as antiviral drugs
por: Jayaseelan, Vijayashree Priyadharsini, et al.
Publicado: (2020)